JTH/LinkedIn
Jun 23, 2026, 13:44
How Sickle Hemoglobin Fuels Thrombosis and Vascular Injury – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jintao Wang et al, published in Journal of Thrombosis and Haemostasis, adding:
“Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
In sickle cell disease mice, sickle hemoglobin shortens clotting time and drives venous thrombosis, while hemoglobinase (plasmepsin I) therapy reduces free hemoglobin and thrombus size.”
Title: Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
Authors: Jintao Wang, Paul Silaghi, Daniel T. Eitzman
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 14:26James Crowley: The Hidden Burden of Atrial Fibrillation
-
Jun 23, 2026, 14:15Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation
-
Jun 23, 2026, 13:30Amit Malhotra: The Expanding Role of Upadacitinib Across Autoimmune and Inflammatory Disorders
-
Jun 23, 2026, 13:10Scott Cameron: Olfactory Receptor Signaling as a Druggable Target in Cardiovascular Disease
-
Jun 23, 2026, 12:52Zain Khalpey: Understanding the Mechanisms of Sudden Cardiac Death
-
Jun 23, 2026, 12:43Victoria Azodoh: Strengthening Maternal Nutrition Through Evidence-Based Action
-
Jun 23, 2026, 12:37Sophia Delicou: Featured on the Cover of the British Journal of Haematology
-
Jun 23, 2026, 12:29Mattia Liverani։ AHA Highlights New Approaches in Iron Deficiency Management
-
Jun 23, 2026, 12:19Maha Sallam: What Baseline Hemoglobin Reveals About SCA